Extracellular Vesicles and Tumor-Immune Escape: Biological Functions and Clinical Perspectives
The modulation of the immune system is one of the hallmarks of cancer. It is now widely described that cancer cells are able to evade the immune response and thus establish immune tolerance. The exploration of the mechanisms underlying this ability of cancer cells has always attracted the scientific...
Main Authors: | Stefania Raimondo, Marzia Pucci, Riccardo Alessandro, Simona Fontana |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/7/2286 |
Similar Items
-
Classical Hodgkin’s Lymphoma in the Era of Immune Checkpoint Inhibition
by: Valli De Re, et al.
Published: (2019-10-01) -
Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5
by: Yang Liu, et al.
Published: (2020-12-01) -
High intensity interval exercise increases the frequency of peripheral PD-1+ CD8+ central memory T-cells and soluble PD-L1 in humans
by: Alex J. Wadley, et al.
Published: (2020-03-01) -
Extracellular Vesicles From Gastric Cancer Cells Induce PD-L1 Expression on Neutrophils to Suppress T-Cell Immunity
by: Yinghong Shi, et al.
Published: (2020-05-01) -
Immune checkpoint blockade therapy for bladder cancer treatment
by: Jayoung Kim
Published: (2016-06-01)